Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Homoharringtonine

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 690,870Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Exclusive: U.S. drug benefit managers clamp down on specialty pharmacies
    Exclusive: U.S. drug benefit managers clamp down on specialty pharmacies

    16 Nov 2015

    // Caroline Humer REUTERS

    http://www.reuters.com/article/2015/11/15/us-healthcare-pharmacies-terminations-ex-idUSKCN0T40WF20151115#REQY6Dg2pHX8S1gw.97

    Caroline Humer REUTERS
    16 Nov 2015
    Share Share
    No real rationale for rising cancer drug prices, JAMA researchers conclude
    No real rationale for rising cancer drug prices, JAMA researchers conclude

    08 Apr 2015

    // Tracy Staton FIERCE PHARMA

    http://www.fiercepharma.com/story/no-real-rationale-rising-cancer-drug-prices-jama-researchers-conclude/2015-04-07

    Tracy Staton FIERCE PHARMA
    08 Apr 2015
    Share Share